Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics

Stock Information for Codexis Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Codexis Inc.

Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference
Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics
Codexis Announces Appointment of Raymond De Vré, PhD, to Board of Directors
Codexis Announces New Employment Inducement Grants
Codexis to Participate in Upcoming Healthcare Conferences
Codexis Reports Third Quarter 2024 Financial Results
Codexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual Meeting
Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.